Evaluation of Vepoloxamer in Chronic Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Conditions
Chronic Heart Failure
Interventions
DRUG

Vepoloxamer

OTHER

5% dextrose in water

Trial Locations (4)

2285

Research Center, Cardiff

38801

Research Center, Tupelo

48202

Research Center, Detroit

Unknown

Research Center, Melbourne

Sponsors
All Listed Sponsors
lead

Mast Therapeutics, Inc.

INDUSTRY

NCT02596477 - Evaluation of Vepoloxamer in Chronic Heart Failure | Biotech Hunter | Biotech Hunter